ISDA

Entry Detail

PDB ID:

6NO9

Keywords:

Title:

PIM1 in complex with Cpd16 (5-amino-N-(5-((4R,5R)-4-amino-5-fluoroazepan-1-yl)-1-methyl-1H-pyrazol-4-yl)-2-(2,6-difluorophenyl)thiazole-4-carboxamide)

Biological Source:

Source Organism:

Homo sapiens

Host Organism:

Escherichia coli BL21(DE3)

PDB Version:

Deposition Date:

2019-01-15

Release Date:

2019-02-27

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

1.71 Å

R-Value Free:

0.20

R-Value Work:

0.16

R-Value Observed:

0.16

Space Group:

P 65

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Description:Serine/threonine-protein kinase pim-1
Chain IDs:A
Chain Length:273
Number of Molecules:1
Biological Source:Homo sapiens

UniProt ID:P11309 Pfam ID:PF00069 EC:2.7.11.1

Ligand Molecules

GOL

KUV

PO4

Primary Citation

Optimization of Pan-Pim Kinase Activity and Oral Bioavailability Leading to Diaminopyrazole (GDC-0339) for the Treatment of Multiple Myeloma.

Wang, X, Blackaby, W, Allen, V, Chan, G.K.Y, Chang, J.H, Chiang, P.C, Diene, C, Drummond, J, Do, S, Fan, E, Harstad, E.B, Hodges, A, Hu, H, Jia, W, Kofie, W, Kolesnikov, A, Lyssikatos, J.P, Ly, J, Matteucci, M, Moffat, J.G, Munugalavadla, V, Murray, J, Nash, D, Noland, C.L, Del Rosario, G, Ross, L, Rouse, C, Sharpe, A, Slaga, D, Sun, M, Tsui, V, Wallweber, H, Yu, S.F, Ebens, A.J.Show

J. Med. Chem. 62 2140 2153 (2019)

PMID: 30715878 DOI: 10.1021/acs.jmedchem.8b01857

Abstact

Pim kinases have been targets of interest for a number of therapeutic areas. Evidence of durable single-agent efficacy in human clinical trials validated Pim kinase inhibition as a promising therapeutic approach for multiple myeloma patients. Here, we report the compound optimization leading to GDC-0339 (16), a potent, orally bioavailable, and well tolerated pan-Pim kinase inhibitor that proved efficacious in RPMI8226 and MM.1S human multiple myeloma xenograft mouse models and has been evaluated as an early development candidate.

Legend

Protein

Chemical

Disease

Primary Citation of related structures